Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $381.7800 (2.52%) ($371.6500 - $382.3100) on Fri. Dec. 23, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.68% (three month average) | RSI | 58 | Latest Price | $381.7800(2.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(41%) IWF(41%) | Factors Impacting REGN price | REGN will decline at least -1.34% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.34% (StdDev 2.68%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
5 Day Moving Average | $372.4(2.52%) | 10 Day Moving Average | $376.7(1.35%) | 20 Day Moving Average | $375.76(1.6%) | To recent high | -14.1% | To recent low | 13.6% | Market Cap | $40.48b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |